vs
Side-by-side financial comparison of Freshworks Inc. (FRSH) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $228.6M, roughly 1.2× Freshworks Inc.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -2.1%, a 2.8% gap on every dollar of revenue. On growth, Freshworks Inc. posted the faster year-over-year revenue change (16.5% vs -16.5%).
Freshworks Inc. is a cloud-based software-as-a-service company, founded in 2010 in Chennai, India. The company provides cloud-based tools for customer relationship management (CRM), IT service management (ITSM), and e-commerce marketing.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
FRSH vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $228.6M | $270.8M |
| Net Profit | $-4.8M | $2.0M |
| Gross Margin | 84.8% | 37.7% |
| Operating Margin | 11.6% | -13.2% |
| Net Margin | -2.1% | 0.7% |
| Revenue YoY | 16.5% | -16.5% |
| Net Profit YoY | -268.9% | -83.6% |
| EPS (diluted) | $-0.02 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $228.6M | — | ||
| Q4 25 | $222.7M | $270.8M | ||
| Q3 25 | $215.1M | — | ||
| Q2 25 | $204.7M | $277.7M | ||
| Q1 25 | $196.3M | $324.5M | ||
| Q4 24 | $194.6M | — | ||
| Q3 24 | $186.6M | — | ||
| Q2 24 | $174.1M | $305.7M |
| Q1 26 | $-4.8M | — | ||
| Q4 25 | $191.4M | $2.0M | ||
| Q3 25 | $-4.7M | — | ||
| Q2 25 | $-1.7M | $455.0M | ||
| Q1 25 | $-1.3M | $11.9M | ||
| Q4 24 | $-21.9M | — | ||
| Q3 24 | $-30.0M | — | ||
| Q2 24 | $-20.2M | $25.8M |
| Q1 26 | 84.8% | — | ||
| Q4 25 | 85.6% | 37.7% | ||
| Q3 25 | 84.7% | — | ||
| Q2 25 | 84.8% | 0.1% | ||
| Q1 25 | 84.8% | 48.0% | ||
| Q4 24 | 84.9% | — | ||
| Q3 24 | 84.0% | — | ||
| Q2 24 | 83.8% | 41.1% |
| Q1 26 | 11.6% | — | ||
| Q4 25 | 17.8% | -13.2% | ||
| Q3 25 | -3.5% | — | ||
| Q2 25 | -4.2% | -1.3% | ||
| Q1 25 | -5.3% | -5.0% | ||
| Q4 24 | -12.2% | — | ||
| Q3 24 | -20.8% | — | ||
| Q2 24 | -25.1% | -9.0% |
| Q1 26 | -2.1% | — | ||
| Q4 25 | 86.0% | 0.7% | ||
| Q3 25 | -2.2% | — | ||
| Q2 25 | -0.8% | 163.8% | ||
| Q1 25 | -0.7% | 3.7% | ||
| Q4 24 | -11.3% | — | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -11.6% | 8.4% |
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.66 | $0.00 | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.01 | $0.52 | ||
| Q1 25 | $0.00 | $0.01 | ||
| Q4 24 | $-0.07 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | $-0.07 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $548.2M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $1.0B | $1.2B |
| Total Assets | $1.6B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $548.2M | — | ||
| Q4 25 | $781.4M | $1.4B | ||
| Q3 25 | $813.2M | — | ||
| Q2 25 | $926.2M | $1.4B | ||
| Q1 25 | $995.3M | $836.1M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.2B | ||
| Q3 25 | $851.5M | — | ||
| Q2 25 | $984.6M | $1.2B | ||
| Q1 25 | $1.1B | $759.9M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | $740.1M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.8B | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.5B | $1.8B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.5B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $62.4M | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $62.4M | — | ||
| Q4 25 | $62.3M | $8.2M | ||
| Q3 25 | $63.5M | — | ||
| Q2 25 | $58.6M | $-72.9M | ||
| Q1 25 | $58.0M | $40.3M | ||
| Q4 24 | $41.4M | — | ||
| Q3 24 | $42.3M | — | ||
| Q2 24 | $36.3M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | $60.1M | $3.4M | ||
| Q3 25 | $61.7M | — | ||
| Q2 25 | $58.2M | $-82.2M | ||
| Q1 25 | $56.7M | $32.5M | ||
| Q4 24 | $36.3M | — | ||
| Q3 24 | $41.3M | — | ||
| Q2 24 | $34.0M | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | 27.0% | 1.2% | ||
| Q3 25 | 28.7% | — | ||
| Q2 25 | 28.4% | -29.6% | ||
| Q1 25 | 28.9% | 10.0% | ||
| Q4 24 | 18.7% | — | ||
| Q3 24 | 22.1% | — | ||
| Q2 24 | 19.5% | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | 1.8% | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.2% | 3.3% | ||
| Q1 25 | 0.7% | 2.4% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.3% | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | 4.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.